Rimonabant, a Cannabinoid Receptor Type 1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating Liver Kinase B1 and AMP-Activated Protein Kinase Axis Downstream of Gαi/o Inhibition

2011 ◽  
Vol 80 (5) ◽  
pp. 859-869 ◽  
Author(s):  
Hong Min Wu ◽  
Yoon Mee Yang ◽  
Sang Geon Kim
Keyword(s):  
Protein Kinase ◽  
Cannabinoid Receptor ◽  
Inverse Agonist ◽  
Receptor Type ◽  
Cannabinoid Receptor Type 1 ◽  
Liver Kinase B1 ◽  
Amp Activated Protein Kinase

Inverse agonist of ERRγ reduces cannabinoid receptor type 1-mediated induction of fibrinogen synthesis in mice with a high-fat diet-intoxicated liver

2018 ◽  
Vol 92 (9) ◽  
pp. 2885-2896 ◽  
Author(s):  
Yaochen Zhang ◽  
Don-Kyu Kim ◽  
Yoon Seok Jung ◽  
Yong-Hoon Kim ◽  
Yong Soo Lee ◽  
...  
Keyword(s):  
High Fat Diet ◽  
Cannabinoid Receptor ◽  
Inverse Agonist ◽  
Receptor Type ◽  
High Fat ◽  
Cannabinoid Receptor Type 1

Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome

2017 ◽  
Vol 112 (6) ◽  
pp. 933-939 ◽  
Author(s):  
Andrzej Wasilewski ◽  
Urszula Lewandowska ◽  
Paula Mosinska ◽  
Cezary Watala ◽  
Martin Storr ◽  
...  
Keyword(s):  
Opioid Receptor ◽  
Cannabinoid Receptor ◽  
Mu Opioid Receptor ◽  
Receptor Type ◽  
Cyclic Vomiting Syndrome ◽  
Mu Opioid ◽  
Cannabinoid Receptor Type 1 ◽  
Cyclic Vomiting
Sign in / Sign up

Export Citation Format

Share Document